SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-144575
Filing Date
2020-05-18
Accepted
2020-05-18 08:31:02
Documents
4
Period of Report
2020-05-18
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d934428d8k.htm 8-K 27490
2 EX-99.1 d934428dex991.htm EX-99.1 19569
3 GRAPHIC g934428g0517082703042.jpg GRAPHIC 3250
4 GRAPHIC g934428g0517082703276.jpg GRAPHIC 2708
  Complete submission text file 0001193125-20-144575.txt   56689
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 20888126
SIC: 2834 Pharmaceutical Preparations